Last Week in Medicine

Race and Estimated GFR, Bleeding Risk in Oral Anticoagulation after First VTE, HEP-COVID trial, High Dose Dexamethasone for COVID-19

Stephen Jenkins, MD; Austin Rupp, MD Season 3 Episode 2

Today we talk about the effect of eliminating the race coefficient from the estimated GFR calculators, the risk of bleeding from anticoagulation after first unprovoked VTE, another trial looking at therapeutic anticoagulation in COVID-19, and whether 12 mg of dexamethasone is better than 6 mg for severe COVID-19 infections.


New GFR Equations without Race

Race, Genetic Ancestry and Estimating Kidney Function

Long Term Bleeding Risk from Oral AC after First Unprovoked VTE

Therapeutic Heparin for COVID-19 (HEP-COVID)

High Dose Dexamethasone for Severe COVID-19




Music from Uppbeat (free for Creators!):

https://uppbeat.io/t/soundroll/dope

License code: NP8HLP5WKGKXFW2R